XML 17 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2016
Dec. 31, 2015
Current Assets    
Cash and cash equivalents (variable interest entity restricted - 2016: $22; 2015: $7) $ 1,252 $ 967
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2016: $6; 2015: $6; variable interest entity restricted - 2016: $5; 2015: $6) 791 706
Non-trade receivables, net 214 285
Inventories 652 682
Deferred income taxes 0 68
Marketable securities, at fair value 34 30
Other assets 35 49
Total current assets 2,978 2,787
Investments in affiliates 864 838
Property, plant and equipment (net of accumulated depreciation - 2016: $2,228; 2015: $2,039; variable interest entity restricted - 2016: $744; 2015: $772) 3,578 3,609
Deferred income taxes   222
Deferred income taxes 216  
Other assets (variable interest entity restricted - 2016: $9; 2015: $13) 290 300
Goodwill 712 705
Intangible assets (net of accumulated amortization - 2016: $542; 2015: $528; variable interest entity restricted - 2016: $26; 2015: $27) 119 125
Total assets 8,757 8,586
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 92 513
Trade payables - third party and affiliates 591 587
Other liabilities 299 330
Deferred income taxes 0 30
Income taxes payable 116 90
Total current liabilities 1,098 1,550
Long-term debt, net of unamortized deferred financing costs 2,923 2,468
Deferred income taxes   136
Deferred income taxes 139  
Uncertain tax positions 101 167
Benefit obligations 1,124 1,189
Other liabilities 221 247
Commitments and Contingencies
Stockholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2016 and 2015: 0 issued and outstanding) 0 0
Treasury stock, at cost (2016: 24,277,107 shares; 2015: 19,916,490 shares) (1,331) (1,031)
Additional paid-in capital 140 136
Retained earnings 4,211 3,621
Accumulated other comprehensive income (loss), net (310) (348)
Total Celanese Corporation stockholders' equity 2,710 2,378
Noncontrolling interests 441 451
Total equity 3,151 2,829
Total liabilities and equity 8,757 8,586
Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2016: 167,476,602 issued and 143,199,495 outstanding; 2015: 166,698,787 issued and 146,782,297 outstanding)    
Stockholders' Equity    
Common stock 0 0
Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2016 and 2015: 0 issued and outstanding)    
Stockholders' Equity    
Common stock $ 0 $ 0